Back to Search Start Over

Metastatic hidradenocarcinoma: a report of two rare cases.

Authors :
Amoedo P
Cerejeira A
Moreira F
Coelho A
Barros AM
Moreira E
Magina S
Silva-Ramos M
Azevedo F
Source :
European journal of dermatology : EJD [Eur J Dermatol] 2023 Jun 01; Vol. 33 (3), pp. 241-244.
Publication Year :
2023

Abstract

Background: Hidradenocarcinoma is a rare malignant sweat gland tumour, characterized by a slow but aggressive course, with high rates of local recurrence and metastasis. Due to its rarity, histological criteria and therapeutic guidelines are poorly defined, posing a major challenge for clinicians and pathologists.<br />Objectives: To present two new cases of metastatic hidradenocarcinoma as well as a review of the literature.<br />Materials & Methods: We describe two case studies and a review of the literature based on a search using the MEDLINE (PubMed) electronic database.<br />Results: The first patient was a 61-year-old woman with a perimamillary hidradenocarcinoma that arose from the malignant transformation of a benign childhood lesion and developed regional lymph node metastases after wide excision and adjuvant radiotherapy. The second patient was a 63-year-old man who developed cutaneous and renal metastases several years after the complete excision of a lumbar hidradenocarcinoma. As far as we can ascertain, kidney metastasis from hidradenocarcinoma has not previously been described.<br />Conclusion: Most authors recommend wide excision as the treatment of choice for hidradenocarcinoma, however, optimal adjuvant therapy remains to be determined. Our cases add to the limited knowledge available, but high-quality studies to find new effective treatments are needed.

Details

Language :
English
ISSN :
1952-4013
Volume :
33
Issue :
3
Database :
MEDLINE
Journal :
European journal of dermatology : EJD
Publication Type :
Academic Journal
Accession number :
37594329
Full Text :
https://doi.org/10.1684/ejd.2023.4478